These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8560070)

  • 1. [Hematopoietic growth factors in iatrogenic neutropenia in oncology].
    Klastersky J
    Rev Mal Respir; 1995; 12(5):407-8. PubMed ID: 8560070
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
    Moreno García M; Fernández González F
    Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antimicrobial therapy in neutropenia].
    Maschmeyer G; Vogt K; Hahn H; Dörken B
    Dtsch Med Wochenschr; 1997 Jul; 122(27):864-9. PubMed ID: 9280698
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of hematopoietic growth factors in bronchial cancerology].
    Lemarié E; Milleron B
    Rev Mal Respir; 1995; 12(5):429-34. PubMed ID: 8560073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use].
    Paul C; Hast R
    Lakartidningen; 2000 Jun; 97(23):2862-6. PubMed ID: 10885223
    [No Abstract]   [Full Text] [Related]  

  • 7. Are guidelines on use of colony-stimulating factors in solid cancers flawed?
    Haines IE; Olver I
    Intern Med J; 2009 Apr; 39(4):259-62. PubMed ID: 19402867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic growth factors and chemoprotectants: should we move toward a two-step process for phase I clinical trials in oncology?
    Merrouche Y; Catimel G; Clavel M
    Ann Oncol; 1993 Jun; 4(6):471-4. PubMed ID: 8353088
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing hematologic toxicities in the oncology patient.
    Montoya L
    J Infus Nurs; 2007; 30(3):168-72. PubMed ID: 17505218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of infection in children with bone marrow failure.
    Hann IM
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):441-56. PubMed ID: 11030044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing hematologic toxicities.
    Capo G; Waltzman R
    J Support Oncol; 2004; 2(1):65-79. PubMed ID: 15330374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the management of chemotherapy-induced neutropenia.
    Dale DC
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):679-84. PubMed ID: 16258470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic growth factors in cancer chemotherapy.
    Lieschke GJ; Foote M; Morstyn G
    Cancer Chemother Biol Response Modif; 1997; 17():363-89. PubMed ID: 9551221
    [No Abstract]   [Full Text] [Related]  

  • 14. [Infection therapy in neutropenia].
    Adam D
    Dtsch Med Wochenschr; 1999 Apr; 124 Suppl 1():S2. PubMed ID: 10410647
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hematopoietic growth factors].
    Fillet G
    Rev Med Liege; 1996 Jan; 51(1):102-6. PubMed ID: 8701118
    [No Abstract]   [Full Text] [Related]  

  • 16. [Empirical antimicrobial therapy in neutropenic patients].
    Maschmeyer G
    Ther Umsch; 1996 Nov; 53(11):854-62. PubMed ID: 8984691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The application of hematopoietic growth factors in oncology].
    Hoekman K; Wagstaff J; Ossenkoppele GJ; Pinedo HM
    Ned Tijdschr Geneeskd; 1991 Mar; 135(10):409-14. PubMed ID: 2020312
    [No Abstract]   [Full Text] [Related]  

  • 18. Current and future use of hematopoietic growth factors in cancer medicine.
    Mughal TI
    Hematol Oncol; 2004 Sep; 22(3):121-34. PubMed ID: 15991222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth factors].
    Spaëth D; Geoffrois L; Conroy T
    Bull Cancer; 2000 Jan; 87(1):93-6. PubMed ID: 10673637
    [No Abstract]   [Full Text] [Related]  

  • 20. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Sheridan WP
    Cancer Chemother Biol Response Modif; 1993; 14():353-70. PubMed ID: 8312108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.